Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02203513
Brief Title: A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer

First Submitted : July 29, 2014
First Submitted that Met QC Criteria : July 29, 2014
First Posted : July 30, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : February 18, 2021
Last Update Posted : February 21, 2021